Lexington is seeing a trend of new biotech businesses locating to town with most of them moving in from Cambridge.
BizJournal.com reported that a number of pharmaceutical and biotech firms have either moved to Lexington in the last few years or are looking to move to town. The biggest to move thus far is the British-based pharmaceutical giant Shire, which in 2010 paid $165 million for and invested more than $500 million in a four-building campus in town for its Human Genetics Therapies division.
Since then other businesses, including T2 Biosystems, Abpro, Acusphere, Cubist Pharmaceuticals, Promedior, and Synta Pharmaceuticals have followed Shire into town. According to the story there are multiple reasons why the companies are coming to town. For starters there is more space and rent is cheaper. The Town of Lexington has also helped by providing infrastructure needed for biotech companies. Lexington's location near Routes 2,3 and 128, along with the Mass Pike, are also factors.